Suchergebnisse - "Stagno, Fabio"

PubPharm (18)

1

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib : 10-year followup of the GIMEMA CML 0307 study

enthalten in: Haematologica | 2022

von Gugliotta, G. | Castagnetti, F. | Breccia, M. | +23

2

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials : a real-life cohort observational study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Stagno, F. | Breccia, M. | Annunziata, M. | +24

3

Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

enthalten in: Annals of hematology | 2021

von Caocci, G. | Mulas, O. | Capodanno, I. | +33

CommentIn: Ann Hematol. 2021 May;100(5):1335-1336. - PMID 33474630

4

Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study

enthalten in: Leukemia | 2021

von Breccia, M. | Pregno, P. | Castagnetti, F. | +13

5

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs : First interim analysis of OPTkIMA study

enthalten in: Cancer medicine | 2021

von Malagola, M. | Iurlo, A. | Abruzzese, E. | +29

ErratumIn: Cancer Med. 2021 May 2;:. - PMID 33934555

6

Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib

enthalten in: Frontiers in oncology | 2021

von Loscocco, F. | Visani, G. | Ruzzo, A. | +12

7

Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy : A Case Report

enthalten in: In vivo (Athens, Greece) | 2020

von Manzella, L. | Tirrò, E. | Vitale, S. | +9

8

Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors

enthalten in: International journal of cardiology | 2020

von Caocci, G. | Mulas, O. | Annunziata, M. | +31

9

Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript : A case report

enthalten in: Oncology letters | 2019

von Massimino, M. | Stella, S. | Tirrò, E. | +9

10

Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)

enthalten in: Anticancer research | 2019

von Tirrò, E. | Massimino, M. | Stella, S. | +12